Jack Nielsen - 10 Jun 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Issuer symbol
RETA
Transactions as of
10 Jun 2021
Transactions value $
$99,971
Form type
4
Filing time
14 Jun 2021, 11:26:03 UTC
Previous filing
14 Jun 2021
Next filing
15 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Award $0 +5,000 $0 5,000 10 Jun 2021 Class A common stock 5,000 $146.01 Direct F1
transaction RETA Stock Option (right to buy) Award $99,971 +1,201 $83.24 1,201 10 Jun 2021 Class A common stock 1,201 $146.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 4 equal installments on September 10, 2021, December 10, 2021, March 10, 2022, and June 10, 2022, subject to continued service through each vesting date.
F2 The options vest in the following installments: 300 shares on September 10, 2021, December 10, 2021 and March 10, 2022, respectively, and 301 shares June 10, 2022, subject to continued service through each vesting date.
F3 This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $100,000.